510(k) K851283
K851283 is an FDA 510(k) premarket notification submitted by Cooper Biomedical, Inc. for the device "RADIAL IMMUNODIFFUSION PLATES-CERULOPLASMIN". The FDA issued a decision of Substantially Equivalent on May 23, 1985. The device falls under product code DDB (Ceruloplasmin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5210. Cooper Biomedical, Inc. has 18 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 23, 1985
- Date Received
- Apr 1, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Ceruloplasmin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5210
- Review Panel
- IM
- Submission Type
- 510(k) Exempt
Need the full FDA record for Cooper Biomedical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.